Patent Foramen Ovale
Key Points
Key Points
- For patients with cryptogenic stroke and PFO, percutaneous PFO closure probably reduces the risk of stroke recurrence (HR-0.41, summary rate difference -0.67% per year), probably is associated with a periprocedural complication rate of 3.9%, and probably is associated with the development of serious non-periprocedural atrial fibrillation (RR-2.72, summary rate difference 0.33% per year).
- For patients with cryptogenic stroke and PFO, anticoagulation medication and antiplatelet medication are possibly equally effective at reducing recurrent stroke.
Management
Management
...ons Regarding Percutaneous PFO Closure...
...ng considered for PFO closure, clinicians should...
...tients being considered for PFO closure, clini...
...eing considered for PFO closure, clinicians should...
In patients being considered for PFO closur...
...patients being considered for PFO cl...
...patients being considered for PFO closure...
...ients being considered for PFO closure, clinician...
...patients being considered for PFO closure...
...ndergoing PFO closure, patients should be assess...
...risk alternative mechanism of stroke is identifi...
...ore undergoing PFO closure, patients...
...a PFO detected after stroke and no other e...
...nts younger than 60 years with a P...
...inform patients that presence of a large shun...
...FO closure may be offered in other population...
...y be offered to younger patients (e.g.,...
...t for whom PFO closure is being considered, a sh...
...tions Regarding Medical Therapy...
...tients who opt to receive medical therapy a...
...would otherwise be considered good candidates for...
...Management Algorithm...